Intuitive Surgical’s (ISRG) “Buy” Rating Reaffirmed at BTIG Research

BTIG Research reiterated their buy rating on shares of Intuitive Surgical (NASDAQ:ISRG) in a report published on Wednesday,Benzinga reports. BTIG Research currently has a $571.00 price target on the medical equipment provider’s stock.

A number of other analysts also recently commented on the stock. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Piper Sandler reissued an “overweight” rating and set a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Wells Fargo & Company increased their price target on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Evercore ISI boosted their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 8th. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a $615.00 price objective on shares of Intuitive Surgical in a report on Tuesday, August 19th. Fourteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $594.19.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $438.04 on Wednesday. Intuitive Surgical has a 12-month low of $425.00 and a 12-month high of $616.00. The firm has a market capitalization of $157.03 billion, a price-to-earnings ratio of 61.09, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61. The business has a 50 day simple moving average of $465.33 and a 200 day simple moving average of $500.54.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm’s quarterly revenue was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.78 EPS. On average, equities analysts anticipate that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director directly owned 1,074 shares in the company, valued at approximately $504,898.14. The trade was a 23.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,224 shares of company stock valued at $21,716,492. Company insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors and hedge funds have recently bought and sold shares of the business. Tobam grew its position in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at $27,000. Chilton Capital Management LLC increased its stake in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Elite Financial Inc. acquired a new position in shares of Intuitive Surgical in the first quarter worth $26,000. Finally, Princeton Global Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the second quarter worth $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.